Does LENALIDOMIDE Cause Squamous cell carcinoma? 304 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 304 reports of Squamous cell carcinoma have been filed in association with LENALIDOMIDE (LENALIDOMIDE). This represents 0.1% of all adverse event reports for LENALIDOMIDE.
304
Reports of Squamous cell carcinoma with LENALIDOMIDE
0.1%
of all LENALIDOMIDE reports
29
Deaths
47
Hospitalizations
How Dangerous Is Squamous cell carcinoma From LENALIDOMIDE?
Of the 304 reports, 29 (9.5%) resulted in death, 47 (15.5%) required hospitalization, and 10 (3.3%) were considered life-threatening.
Is Squamous cell carcinoma Listed in the Official Label?
Yes, Squamous cell carcinoma is listed as a known adverse reaction in the official FDA drug label for LENALIDOMIDE.
What Other Side Effects Does LENALIDOMIDE Cause?
Diarrhoea (27,576)
Fatigue (22,956)
Death (19,213)
Off label use (17,017)
Rash (15,794)
Pneumonia (14,807)
Plasma cell myeloma (14,191)
Neuropathy peripheral (10,215)
White blood cell count decreased (9,996)
Constipation (9,635)
What Other Drugs Cause Squamous cell carcinoma?
ADALIMUMAB (456)
RUXOLITINIB (413)
TACROLIMUS (327)
INFLIXIMAB (313)
RITUXIMAB (313)
PREDNISONE (267)
RANITIDINE (260)
CYCLOSPORINE (254)
METHOTREXATE (252)
USTEKINUMAB (246)
Which LENALIDOMIDE Alternatives Have Lower Squamous cell carcinoma Risk?
LENALIDOMIDE vs LENIOLISIB
LENALIDOMIDE vs LENOGRASTIM
LENALIDOMIDE vs LENVATINIB
LENALIDOMIDE vs LEPONEX
LENALIDOMIDE vs LERCANIDIPINE